RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024 - Seite 3

Forward-looking statements included herein are made as of the date hereof, and RenovoRx does not undertake any obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240405398904/en/

The RenovoRx Stock at the time of publication of the news with a fall of -1,61 % to 1,220USD on Nasdaq stock exchange (05. April 2024, 02:00 Uhr).